rs1555392783
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_152594.3(SPRED1):c.1099_1102delAGTT(p.Ser367AlafsTer38) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_152594.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- Legius syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, ClinGen, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Legius syndrome Pathogenic:1
A different truncation downstream of this variant (p.Gly385Ilefs*20) has been determined to be pathogenic (PMID: 19920235, 19443465, 21089071, 17704776). This suggests that deletion of this region of the SPRED1 protein is causative of disease. This sequence change results in a premature translational stop signal in the SPRED1 gene (p.Ser367Alafs*38). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 78 amino acids of the SPRED1 protein. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SPRED1-related disease. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at